What podcasts say about Mark Hyman
Every statement, with the speaker, the exact quote and the moment it was said.
What Mark Hyman has said on podcasts
24 statements · 16 positive · 4 negative · 4 mixed
Function gives people agency and access to their personal health biology.
“Function is really about giving people agency. Democratizing healthcare and allowing people access to their own biology.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 3:27
Functional medicine treats the body as an interconnected system.
“functional medicine is a framework for understanding the body as a network, not as a bunch of organs and parts, but actually as a cohesive system”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 5:37
Function tests over 160 biomarkers twice yearly for approximately one dollar daily.
“over 160 biomarkers tested twice a year, plus add-ons if you want for $1 a day”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 9:02
Function reports elevated insulin in approximately 65% of its tested population.
“We're seeing like 65% with high insulin levels, which never get checked.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 12:32
Galleri screens over 50 cancers with approximately 75% detection and low false positives.
“it looks at over 50 different cancers. It's about 75% good at picking up things, doesn't get everything all the time, um, and it has very low false positive rates.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 14:07
AI will increasingly interpret large-scale personal health data.
“we're gonna be entering an era where, where we're gonna start to be able to make sense of all this data with AI”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 20:26
MRI has no downside because it does not use ionizing radiation.
“There's no downside to an MRI. It's basically non-radiation.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 21:54
Early-stage cancer is curable, unlike cancer detected at stages three or four.
“if you find a cancer at an early stage, it's curable. Stage 1 is curable, whereas if you wait till 3 or 4, it's definitely not.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 22:48
AI decision support will become central to provider and personal healthcare.
“using AI as decision support for providers and for your own personal health is really where we're all going”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 25:33
Medical AI is not ready for unrestricted use without safeguards.
“I don't think we're quite there to unleash it without any guardrails.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 27:42
Wearables can detect subtle physiological signals indicating health problems.
“through these technologies, pick up very subtle signals where things are off”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 31:54
Tufts data indicates 93% of Americans have some degree of poor metabolic health.
“we've seen 90, according to the data from Tufts, 93% of Americans have some version of this”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 34:56
Everyone should have insulin levels tested.
“insulin is super important, and it's, it's one of those things that I I think everybody should have tested”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 36:16
Short-term glucose monitoring helps people understand food-specific metabolic responses.
“as a way to understand how different foods affect you, it's really important”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 37:07
Balanced blood sugar is essential for healthy aging.
“balanced blood sugar is the key phenomenon that you have to have for healthy aging”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 38:05
GLP-1 drugs cause serious adverse effects in about 4% and digestive issues in about 75%.
“there's about a 4% serious adverse side effect profile with these. Now, 4% doesn't sound like a lot, but if you took 100 million people and put 'em on it, that's 4 million people. And, and about 75% have digestive issues.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 43:08
GLP-1 drugs should target appropriate patients rather than minor cosmetic weight loss.
“used in the right way for the right person, probably not the person who just wants to lose like 5 pounds”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 43:26
GLP-1 microdosing lacks sufficient evidence about long-term benefits and consequences.
“in terms of the microdosing, there's a lot of people doing it. There's not a lot of data on it. It. We don't really know the long-term benefits, consequences.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 44:12
Maintaining muscle is essential for longevity.
“Muscle is the currency of longevity.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 46:38
Strength training can be effective with 20 minutes three times weekly across major muscle groups.
“it can be 20 minutes 3 times a week, but you wanna do all the major muscle groups”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 47:22
Replacing ultra-processed food with whole food reduced juvenile detention violence by 97% in one study.
“they were able to give them whole real food and get rid of the crap. And the violent crime went down by 97% in the juvenile detention center.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 51:39
Lifestyle interventions can treat many psychiatric problems.
“a lot of psychiatric problems can be treated with lifestyle and with foundational things that you talk about”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 53:28
Early psychedelic-therapy evidence is promising but insufficient for broad adoption.
“the data, early data is promising around psilocybin, around MDMA, around ibogaine. We just need more data and it's not ready for primetime yet.”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 56:09
Psychedelic treatments should be administered cautiously and under rigorous scientific oversight.
“it really should be done carefully, rigorously, and scientifically”
Open the episode · Dr. Mark Hyman on Function Health & GLP-1 microdosing | E2334Listen at 56:23
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.